Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
- PMID: 16828192
- DOI: 10.1016/j.jconrel.2006.05.010
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
Abstract
An ultrasonic-solvent emulsification technique was adopted to prepare vinpocetine loaded Glyceryl monostearate (GMS) nanodispersions with narrow size distribution. To increase the lipid load the process was conducted at 50 degrees C, and in order to prepare nanoparticle using an ultrasonic-solvent emulsification technique. The mean particle size and droplet size distribution, drug loading capacity, drug entrapment efficiency (EE%), zeta potential, and long-term physical stability of the SLNs were investigated in detail respectively. Drug release from two sorts of VIN-SLN was studied using a dialysis bag method. A pharmacokinetic study was conducted in male rats after oral administration of 10 mg kg(-1) VIN in different formulations, it was found that the relative bioavailability of VIN in SLNs was significantly increased compared with that of the VIN solution. The amount of surfactant also had a marked effect on the oral absorption of VIN with SLN formulations. The absorption mechanism of the SLN formulations was also discussed. These results indicated that VIN absorption is enhanced significantly by employing SLN formulations. SLNs offer a new approach to improve the oral bioavailability of poorly soluble drugs.
Similar articles
-
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.J Pharm Pharmacol. 2004 Dec;56(12):1527-35. doi: 10.1211/0022357044959. J Pharm Pharmacol. 2004. PMID: 15563759
-
Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.Int J Pharm. 2010 Jul 15;394(1-2):179-85. doi: 10.1016/j.ijpharm.2010.05.005. Epub 2010 May 13. Int J Pharm. 2010. PMID: 20471464
-
Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.Eur J Pharm Biopharm. 2017 Jan;110:47-57. doi: 10.1016/j.ejpb.2016.10.022. Epub 2016 Oct 31. Eur J Pharm Biopharm. 2017. PMID: 27810472
-
Nanostructured lipid carriers and their current application in targeted drug delivery.Artif Cells Nanomed Biotechnol. 2016;44(1):27-40. doi: 10.3109/21691401.2014.909822. Epub 2014 May 9. Artif Cells Nanomed Biotechnol. 2016. PMID: 24813223 Review.
-
Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method.Curr Drug Deliv. 2010 Jan;7(1):44-50. doi: 10.2174/156720110790396472. Curr Drug Deliv. 2010. PMID: 20044909 Review.
Cited by
-
Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases γ-tocotrienol oral bioavailability.Lipids. 2012 May;47(5):461-9. doi: 10.1007/s11745-012-3655-4. Epub 2012 Jan 24. Lipids. 2012. PMID: 22271424
-
Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages.Res Pharm Sci. 2018 Aug;13(4):288-303. doi: 10.4103/1735-5362.235156. Res Pharm Sci. 2018. PMID: 30065762 Free PMC article.
-
Enhanced oral bioavailability of vinpocetine through mechanochemical salt formation: physico-chemical characterization and in vivo studies.Pharm Res. 2011 Aug;28(8):1870-83. doi: 10.1007/s11095-011-0415-8. Epub 2011 Mar 19. Pharm Res. 2011. PMID: 21424156
-
The role of lipid particle-laden interfaces in regulating the co-delivery of two hydrophobic actives from o/w emulsions.Drug Deliv. 2024 Dec;31(1):2425158. doi: 10.1080/10717544.2024.2425158. Epub 2024 Nov 8. Drug Deliv. 2024. PMID: 39513340 Free PMC article.
-
Effect of squalane on mebendazole-loaded Compritol® nanoparticles.J Biomater Sci Polym Ed. 2015;26(13):868-80. doi: 10.1080/09205063.2015.1061351. Epub 2015 Jul 9. J Biomater Sci Polym Ed. 2015. PMID: 26062393 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources